1 – 10 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Insertion of the CXXC domain of KMT2A into YAP1 : An unusual mechanism behind the formation of a chimeric oncogenic protein
(
- Contribution to journal › Article
-
Mark
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer
(
- Contribution to journal › Article
- 2022
-
Mark
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor
(
- Contribution to journal › Article
- 2020
-
Mark
PHF1 fusions cause distinct gene expression and chromatin accessibility profiles in ossifying fibromyxoid tumors and mesenchymal cells
(
- Contribution to journal › Article
-
Mark
Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma
(
- Contribution to journal › Article
- 2019
-
Mark
Gene fusion involving the insulin-like growth factor 1 receptor in an ALK-negative inflammatory myofibroblastic tumour
(
- Contribution to journal › Article
-
Mark
Undifferentiated pleomorphic sarcomas with PRDM10 fusions have a distinct gene expression profile
(
- Contribution to journal › Article
-
Mark
PRDM10 -rearranged Soft Tissue Tumor : A Clinicopathologic Study of 9 Cases
(
- Contribution to journal › Article
- 2017
-
Mark
In-depth genetic analysis of sclerosing epithelioid fibrosarcoma reveals recurrent genomic alterations and potential treatment targets
(
- Contribution to journal › Article
- 2016
-
Mark
FN1-EGF gene fusions are recurrent in calcifying aponeurotic fibroma.
(
- Contribution to journal › Article